secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2026-07-02T11:30:21+00:00
Accession:  0001683168-26-005233
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals posts investor presentation; no new material details disclosed
--------------------------------------------------------------------------------

- Investor presentation posted on company website on July 2, 2026.
- Filing includes only cover page and forward-looking statements; no financial or operational data.
- No updates on clinical trials, revenue, or guidance provided in this filing.
- Full presentation available on company's website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316826005233/0001683168-26-005233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316826005233/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer